Amoxicillin for
PreclinicalSmall molecule
GSKAmoxicillin for is one of 18 small molecule programs targeting Otitis media. It is currently in Preclinical.
1
Indications
3
Total Trials
0
Active Trials
17
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
23 competitors in Otitis Media
#DrugCompanyPhaseTrials
1Cipro
BayerApproved
Biaxin
AbbVieApproved
Keflex
Eli LillyApproved
Levaquin
WWim Janssens
Approved
Decadron
AAspen Global Incorporated
Approved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Ketek
SanofiPhase 3
Kenalog
BBausch Health Americas, Inc.
Phase 3
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Phase 3
Amoxycillin
MMenzies School of Health Research
Approved
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Amoxicillin for. EMBL-EBI & Wellcome Sanger Institute.
- [4]